New Drug Product: Ibrance

In combination with letrozole, for the treatment of postmenopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer as initial endocrine-based therapy for metastatic disease.

FDA: Dosing Errors with Antibiotic

The Food and Drug Administration (FDA) is warning healthcare providers about the risk for dosing errors with Zerbaxa.

The Fittest City in the U.S. ...

The report's authors – including a panel of 26 health and physical activity experts – looked at U.S. Census data, data from the U.S. Centers for Disease Control and Prevention, and other sources to compile the fittest cities list.

Oseltamivir-Warfarin to Blame for Elevated INR?

A case study in Pediatrics describes the first published report of a potential oseltamivir-warfarin interaction in a child with influenza and hypoplastic left heart syndrome.

Distinctive Causes of Death by State

The most distinctive causes of death for each U.S. state have been mapped in a report published online in the U.S. Centers for Disease Control and Prevention's Preventing Chronic Disease.

When the Doctor is Depressed

The suicides of two medical residents in New York City last fall have thrown a spotlight on a real problem among health care professionals, particularly physicians.

Evidence-Based Care for Atrial Fibrillation

The Preventive Cardiovascular Nurses Association is pleased to provide Evidence-Based Care of the Patient with Atrial Fibrillation: A Call to Action for Nurses and Advanced Practice Nurses. This series of articles is designed to guide and support the clinical practice of those managing patients with atrial fibrillation (AF), the most common cardiac arrhythmia in the United States.

Looking for a Job?

Access our job board to view over 1,​40​0 job openings throughout the US.

Latest News

Resources

Make prescribing decisions with our comparative charts and treatment algorithms. See our recently added and updated charts below.

Download or print easy-to-read disease/condition leaflets for your patients. See our recently added patient information fact sheets below.

Sign Up for Free e-newsletters